| scholarly article | Q13442814 |
| P50 | author | Anders Larsson | Q59163549 |
| Olof Heimbürger | Q65927824 | ||
| Lars Lind | Q65992534 | ||
| Peter Stenvinkel | Q37828656 | ||
| Johan Ärnlöv | Q38620593 | ||
| P2093 | author name string | P Bárány | |
| B Sjöberg | |||
| A R Qureshi | |||
| P2860 | cites work | Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction | Q48395268 |
| Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials | Q48458509 | ||
| Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. | Q50901977 | ||
| Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L. | Q51906910 | ||
| Plasma pentraxin 3 concentration increases in endurance-trained men. | Q53321505 | ||
| The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. | Q53496784 | ||
| Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. | Q53510759 | ||
| Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis | Q56942567 | ||
| Inflammation enhances cardiovascular risk and mortality in hemodialysis patients | Q78163875 | ||
| Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality | Q81153028 | ||
| Pentraxin 3, a sensitive early marker of hemodialysis-induced inflammation | Q85647931 | ||
| Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population: a methodological approach | Q85750652 | ||
| Effects of atorvastatin on biomarkers of inflammation in chronic kidney disease | Q86918992 | ||
| Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis | Q26995926 | ||
| Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population | Q28167958 | ||
| Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation | Q29147380 | ||
| Prevalence of chronic kidney disease in the United States | Q29614191 | ||
| PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans | Q33912738 | ||
| Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
| Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction | Q34357988 | ||
| Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis | Q35133148 | ||
| Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients | Q35227705 | ||
| The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps | Q36229261 | ||
| Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease | Q36736700 | ||
| Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria | Q37123175 | ||
| Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study | Q37141153 | ||
| Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease | Q37784542 | ||
| Inflammation in end-stage renal disease--what have we learned in 10 years? | Q37805641 | ||
| Interactions of the humoral pattern recognition molecule PTX3 with the complement system | Q38042225 | ||
| A comparison of three different methods to determine arterial compliance in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study | Q40326708 | ||
| Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients | Q40666223 | ||
| C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients | Q41721897 | ||
| Clinical epidemiology of cardiovascular disease in chronic renal disease | Q43631482 | ||
| Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). | Q43964542 | ||
| Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality | Q44571381 | ||
| Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. | Q44634225 | ||
| Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. | Q44801998 | ||
| International comparison of the relationship of chronic kidney disease prevalence and ESRD risk | Q45273212 | ||
| Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population | Q45356825 | ||
| Prevalence of blood lipid disturbances in Swedish and foreign-born 60-year-old men and women in Stockholm, Sweden | Q46661164 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| P304 | page(s) | 173-179 | |
| P577 | publication date | 2015-09-09 | |
| P1433 | published in | Journal of Internal Medicine | Q6295387 |
| P1476 | title | Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly | |
| P478 | volume | 279 |
| Q37621173 | Association of Pentraxin 3 Gene Polymorphisms with Susceptibility to Diabetic Nephropathy. |
| Q51067081 | Association of genetic variants of pentraxin 3 rs3816527 with hypertension in Chronic kidney disease patients. |
| Q47148726 | Attenuation of partial unilateral ureteral obstruction - induced renal damage with hyperbaric oxygen therapy in a rat model |
| Q47216784 | Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update |
| Q91970155 | Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause Mortality |
| Q40444488 | Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial |
| Q38991073 | Pentraxins in the activation and regulation of innate immunity |
| Q52761490 | Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study. |
| Q58794640 | The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary heart disease—results from the SUPRIM-trial |
| Q91666672 | The role of CRP and Pentraxin 3 in the prediction of systemic inflammatory response syndrome and death in acute pancreatitis |
Search more.